Embryonic Stem Cell-Based Therapeutics: Balancing Scientific Progress and Bioethics

15 Pages Posted: 18 Feb 2010

See all articles by Robert Sackstein

Robert Sackstein

Dana-Farber/Harvard Cancer Center

Ronald Chester

New England Law | Boston

Date Written: February 17, 2010

Abstract

The breakneck speed of scientific developments in embryonic stem (ES) cell technologies is, commensurately, ushering forth new bioethical debate(s) regarding these cells. A framework of bioethical principles is presented here to guide biomedical scientists and others engaged in improving human welfare through the application of ES cell-based therapies.

Keywords: Embryonic Stem Cells

Suggested Citation

Sackstein, Robert and Chester, Ronald, Embryonic Stem Cell-Based Therapeutics: Balancing Scientific Progress and Bioethics (February 17, 2010). Health Matrix: Journal of Law-Medicine, Vol. 20, 2010. Available at SSRN: https://ssrn.com/abstract=1554585

Robert Sackstein

Dana-Farber/Harvard Cancer Center ( email )

641 Huntington Avenue
Boston, MA 02115
United States

Ronald Chester (Contact Author)

New England Law | Boston ( email )

154 Stuart St.
Boston, MA 02116
United States
617-422-7254 (Phone)
617-422-7453 (Fax)

Register to save articles to
your library

Register

Paper statistics

Downloads
204
rank
146,509
Abstract Views
786
PlumX Metrics
!

Under construction: SSRN citations will be offline until July when we will launch a brand new and improved citations service, check here for more details.

For more information